Massachusetts [US], February 14 (ANI): A new clinical study published in The New England Journal of Medicine today and simultaneously presented during the American Society of Clinical Oncology (ASCO) 2021 Genitourinary Cancers Symposium claims that a drug combination of Lenvatinib plus pemb